chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 MINUTES AFTER RECEIVING COVID VACCINE PATIENT REPORTED EXTREME DIZZINESS, AND A FEELING OF FULLNESS IN HER LEGS.  SHE LOOKED PALE AND HER SKIN WAS CLAMY.  GAVE HER SOME WATER AND 1 GLUCOSE TABLET (4GRAM CARBOHYDRATE).  TOOK HER BLOOD PRESSURE AS WAS LOW AT 76/51, RECHECK 86/62, RECHECK, 86/58.  ATTEMPTED TO CALL 911 BUT PATIENT REFUSED AND  WANTED HER DAUGHTER TO COME GET HER.  AT 3:54 PM SHE REPORTED THAT THE DIZZINESS WAS GETTING BETTER AND BLOOD PRESSUER RECHECK WAS 98/68.  AT 4:01 HER BLOOD PRESSURE WAS 117/71 HR 73 THEN EVENTUALLY CAME BACK UP TO 128/80 AT 4:08PM. PATIENT LEFT AT 4:17PM. WILL FOLLOW UP WITH A PHONE CALL TODAY.
At first my left hand started hurting quickly after the shot.  Within about 10 minutes I felt pretty lightheaded but sometimes my blood pressure does drop randomly.  I was able to rest and eat before driving home.   Within a few hours I felt a burning pain in my sinuses, then fatigue and fever.  I felt exhausted/feverish for about two days but mildly improved over the last few days.   I still feel bad but not as bad as initially.
(Inactivated Influenza) Vaccine administered at 1:00pm, at 2:00am the following morning I suffered from stomach cramps and vomitting (although limited since my stomach was empty). The following day I was dizzy and weak with stomach ache.
This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced liver issue, and pancreas issue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the liver issue and pancreas issue was not reported. This report was non-serious.
Pt had hallucinations and was seeing red for 24 hours after vaccination. This has since cleared up.
Pink papules and vessicles on chest, back and abdomen.  [Got varicella] treatment.  Aveeno baths and Benadryl as occasion requires for itch.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 66.52 for dose administered on 31-Mar-2021 and 66.44 for dose administered on 03-Mar-2021.  No concomitant medications were reported.  Batch number 014M20A underwent temperature excursion on 03-Mar-2021 with temperature 51 degrees Fahrenheit from 12:00 PM to 01:00 PM. This vial was moved to fridge on 24-Feb-2021 and beyond use date for the vial was reported as 26-Mar-2021. Product moved to clinic on 03-Mar-2021.  Batch number019B21A underwent temperature excursion on 31-mar-2021 with temperature 32 degrees Fahrenheit from 01:00 PM to 02:00 PM. This vial was moved to fridge on 23-mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 31-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.
Hair is falling out/hair falling out in kind of clumps/has a lot less hair now; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair is falling out/hair falling out in kind of clumps/has a lot less hair now) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Hair is falling out/hair falling out in kind of clumps/has a lot less hair now). At the time of the report, ALOPECIA (Hair is falling out/hair falling out in kind of clumps/has a lot less hair now) outcome was unknown.            No Concomittant medications were reported.  No treatment information was provided.  The patient stated that the hair fall started after taking the two doses of the Moderna COVID-19 vaccine. The patient also stated that she got both of the vaccine in separate arms.
Deziness resulting Ina near fall, mild vertigo, flareup of costochondritis (previouslyhad COVID), Stabbing pains throughout body (mild)
Don't feel good; Temperature of 104; Sick; This case was reported by a consumer via interactive digital media and described the occurrence of feeling unwell in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, less than a day after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced feeling unwell, fever and sickness. On an unknown date, the outcome of the feeling unwell, fever and sickness were recovered/resolved.   It was unknown if the reporter considered the feeling unwell, fever and sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. Years ago in young age, the patient was received flu shot and the patient was did not feel good, had temperature of 104 degree F, went home was so sick for two weeks.  The patient get the flu shot now and don't get sick.
CAN'T RAISE ARM THAT RECEIVED THE INJECTION PAST SHOULDER LEVEL AND OVER MY HEAD AND OTHER VARIOUS POSITIONS.
Rash under arm, swollen lumps on feet, swelling and redness in left deltoid - was swollen then resolved then returned 2 weeks later. Also, an area noted in (R) inguinal area - circular with central clearing. Here last on 6/5. Called to follow up but have not head back yet.
crying & screaming for 4 1/2 hrs (on the day DTP #1 was given);
The second dose of Pediatric Pfizer vaccine was given 7 days earlier (February 3, 2022) than should have been, based on the date of the first dose (January 20th, 2022)
11:30 fainted 10min p/vax were given, vitals were BP 110/60, pulse 60, stated felt nauseated & weak & had a h/a;had a h/a;
5:00 pm 3-9-21  I became instantly exhausted and had fatigue.  I got chills and ran a 99.8 fever.  I went to bed and about 5 hours later my fever broke and I felt fine in the morning when I woke up.  9:30pm  on 3-13-21 I found both of my thighs bright red.  It was not itchy, but it was warm to the touch.  7:45pm on 3-14-21  My butt cheeks were bright red and warm to the touch.  Then about 30 minutes later my thighs became red.  Everything red started itching was raised like hives.  I found three dots on my arm and later those spread into large spots of hives.  Then over the next 9 hours, a new spot would start, it would spread, then it would itch like crazy.  I took 25mg of Diphenhydramine at 8pm.  I took another 50mg at 10 when I was having no relief and it continued to spread.  At 1:15am both of my hands and wrists had hives and these hurt and itched the most because they were swollen and hard to bend.  At 3am both of my feet started to flair up.  Finally around 5am the hives stopped.  I was not able to sleep through it.  I did not ever have a fever, I checked that 4 times.  I also did not have trouble breathing or have any swelling on my face. 3-15-21 @ 9:20am I went to see my doctor.  All of my vitals were good.  All of my hives were gone.  He put me on Prednisone in case it came back and at 11am I took 4 pills and went to bed.  I woke up 2 hours later and my feet were itching again.  My left foot broke out in hives bad.   It lasted for over an hour.  My toes were hard to bend.   4:34pm on 3-15-21 currently I don't have any hives and I am tired.    I thoroughly thought through everything that I have eaten, worn, and used, and I have changed nothing over the past 2 weeks.
Chills; Nausea; Fever; Soreness in arm of injection; A spontaneous report was received from a Consumer concerning a 58-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness in arm of injection, chills, nausea, fever.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 024M20A) intramuscularly for prophylaxis of COVID-19 infection.  On 15 Feb 2021, the patient experienced the events soreness in arm of injection . On 16 Feb 2021, the patient experienced the events chills. nausea, fever.  Treatment details included Tylenol  Action taken with mRNA-1273 in response to the events was not reported.   On 16 Feb 2021 the outcome of events chills was resolved.On 16 Feb 2021 the outcome of events nausea was resolved. On an unknown date the outcome of events, soreness in arm of injection, On an unknown date the outcome of events, fever was not reported.
PATIENT RECEIVED A JANSSEN VACCINE DOSE THAT WAS EXPIRED BY 1 DAY.  LOT # 201A21A EXPIRED ON 09-21-2021 PER MANUFACTURER.
Patient into clinic requesting both meningococcal vaccines prior to starting a new medication for his Myasthenia Gravis. The next evening the spouse reported that the patient experienced extreme head/neck pain and the left arm was painful and weak.  After several days of rest patient reports improvements in symptoms, but reports they are still bothersome. Patient was instructed to follow up with PCP ASAP
Patient came to the Health Department on afternoon of 2/12/21 to report incident.  He received the vaccine approximately 4:20pm.  According to the patient, he felt at his normal all evening.  At 9:15pm, he reports he started having chills and was very cold.  He rested with a blanket until he got up at 9:30pm to get a drink of water and check his temperature.  Per the patient, he remembers checking his temperature, which was 97.6F, then awoke on the floor.  He had passed out, believes he was "out" for no more than a minute.   Patient reports he felt well when he awoke and has felt at his baseline ever since.  He has abrasions to bilateral hands, as well as his chin.  His upper lip was busted.  He did not see his doctor in regards to this.  He admittedly does not see a doctor often.  Encouraged patient to follow up with is doctor, as he states he has a history of a stroke and heart attack.
dizzy, could not walk, talk, hear anything, popped blood vessel in eye. slurred speech We have ordered blood work and a ct scan.
Localized, swelling, erythema and pruritus  at the site of injection 8 days after given vaccine
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning a 35-month-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 05-Feb-2012. The patient received expired FLUMIST on either 07-Feb-2012 or 08-Feb-2012. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
Pt recvd vax & shortly p/vax exp pain in joints, mainly elbows; pain moved up arms to shoulders; currently pt is still exp pain in rt elbow; heavy ache in both wrists; tested borderline for serum sickness;
I administered the vaccine and because the patient has a history of anaphylaxis to nuts, we instructed her to stay in the observation area for 30 minutes, instead of the standard 15 minutes. Patient agreed and was monitored by medical staff in the observation area. She began to feel an adverse reaction (which will be described in further detail by Healthcare staff filling our their VAERS report), and was given supportive measures. She did not have to be transferred out of the observation area, and felt completely recovered after intervention were provided. Please see the additional VAERS report filed on this patient.
Pt was given a Pfizer booster diluted with children Pfizer instead of normal saline. Was given approximately x2 dose. Reporting error to VAERS in case there are future side effects.  Pt stated he had a slight headache and injection site pain the next day but was not experiencing any other side effects.
I was contacted by my district pharmacy manager, he told me that a patient had received an infection from a Moderna COVID vaccination that was given on 01/10/2022. I do not know about adverse events, treatments, and/or outcomes. This was told to me third hand. Never talked to the patient.
Patient started to get HIVES and severe itching the day after vaccine. Her hives did not go away until January 5, 2022.  She is still occasionally itching, a couple times a day. Patient took Benadryl and Prednisone for about 12 days but experienced adverse events for from the steroids and stopped therapy.
Reporting is for a vaccine administration error where an adult patient was administered the Pfizer BioTech vaccine 5-11 years formulation(orange cap), resulting in a lower than authorized dose for a booster. There is currently no adverse event. Patient was notified immediately about the error and the need to return to the pharmacy to receive the correct age appropriate dose of Pfizer-BioTech vaccine booster as per CDC and vaccine manufacturer guidelines. She is yet to return to the pharmacy to receive the correct dose.
Pt recv vax on 10/27/98; 10 min post vax pt exp rt arm sore, 30 min post vax pt exp numbness/ tingling "down a line" of rt arm to hand/fingers, right neck, face & breast; tx=oral fluids, Claritin, ice; dx=allergic rx to thimerosal; pt imp 2
swollen lymph; muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph), MYALGIA (muscle pain) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen lymph), MYALGIA (muscle pain) and CHILLS (Chills).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
PER PT 11:33AM 11/5/21 - PT SAID HE HAD PANCREATITIS AFTER A FEW HOURS (about 8pm) AFTER THE 1ST DOSE.
no additional AE reported; Vaqta involved in temperature excursion on 01/01/2021. Vaccine had been administered to 33 patients; This spontaneous report was received from a medical assistant and refers to a 20-month-old patient of unknown gender. Their concurrent conditions, medical history and concomitant therapies were not provided.   On 29-JAN-2021, the patient was vaccinated with an improperly stored hepatitis A vaccine, inactivated (VAQTA) lot number: T013204, expiration date: 03-DEC-2021 (strength, dose, frequency and route of administration were not reported) as prophylaxis. Administered dose of vaccine experienced a temperature excursion of 47.01 degrees Fahrenheit for 1 minute and 30 seconds. Digital data logger was involved. There was no previous excursion noted. There was no additional adverse event reported.  This is one of 33 reports from the same reporter (original case # 2102USA004059). combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T013204; expirationdate: 03-DEC-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2102USA004059:
This spontaneous report as received from a healthcare worker refers to a patient of unspecified age and gender. No current or historical conditions were reported. On 19-NOV-2014 the patient was vaccinated with the second dose of ROTATEQ (lot # K005394; expiration date: 23-FEB-2016, dosage information was not provided) orally, which was improperly stored. There were no concomitant medications reported. No adverse effect reported. There was no product quality complaint (PQC) involved. The outcome was unknown. This is one of several reports received from the same reporter. Additional information is not expected because the reporter had no further information available.
Her arm is all red; Feels like a ball; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Her arm is all red) and PERIPHERAL SWELLING (Feels like a ball) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065F21A, 040A21A and 030M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced ERYTHEMA (Her arm is all red) and PERIPHERAL SWELLING (Feels like a ball). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) in November 2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Her arm is all red) and PERIPHERAL SWELLING (Feels like a ball) outcome was unknown.            Patient declined to give details of concomitant medications that she takes.
Myalgia, Arthralgia, UrticariaPruritus, After 1st dose - hives on day 7 with arm pit pain. After dose 2 site reactions x 2 days with 3 days of chills & body aches, followed by 1 day of joint pain Narrative:
Acute severe hair loss, started after first dose, then intensified after 2nd dose. Lost about ~70% of hair all over scalp during the following 3 months
Swollen lymph nodes under the right arm.  I am currently taking Tylenol only.  Had the injection on Thursday (02/04) afternoon, did not feel  the discomfort of the swelling until early morning of Saturday (02/06).
Pt was seen for a nurse visit, wrong vaccines given, even noticed upon 5 month visit. Merck called.
COVID (+) WITH SYMPTOMS NASAL CONGESTION, FATIGUE, LOSS OF SMELL AND TASTE BODY ACHES Narrative:
Received influenza vaccine L shoulder on 10/30/06.  Within 20 minutes the upper L arms ached and throbbed intensely.  Pain began to subside after 4 hours but for next weeks had limited range of motion in L arm.  Whenever trying to lift arm expecially when reaching to the right and then lifting or in an abduction motion.  Began heat treaments after 4 weeks of limited mobility.  Treatments helped to relieve symptoms over the next 2 weeks.
Small raise bump noted on her face and neck. Pediatrician notified and advised dad to give 1 tsp of BENADRYL and if symptoms worsen to bring her in to be seen by the doctor.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:  12/20/20 ,PfizerLot#EK5730 2nd dose:  01/08/21, Pfizer Lot# EL3248 Diagnosed covid positive:03/31/21 Exposure:unknown Symptoms:Fatigue,Muscle ache,Runny Nose
SYNCOPE WITHIN 10 MINUTES. PATIENT REGAINED CONSCIOUSNESS ALMOST IMMEDIATELY. EMS RESPONDED AND BLOOD PRESSURE REMAINED VERY LOW FOR ANOTHER 15 MINUTES. SUBJECT WAS REFERRED TO AN URGENT CARE CLINIC
Blackened stool; Loose stool; Did not want to walk; This spontaneous case was reported by an other health care professional and describes the occurrence of FAECES DISCOLOURED (Blackened stool), DIARRHOEA (Loose stool) and GAIT DISTURBANCE (Did not want to walk) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Alzheimer's disease, Colitis and No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced FAECES DISCOLOURED (Blackened stool), DIARRHOEA (Loose stool) and GAIT DISTURBANCE (Did not want to walk). At the time of the report, FAECES DISCOLOURED (Blackened stool), DIARRHOEA (Loose stool) and GAIT DISTURBANCE (Did not want to walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Very limited information regarding this event/s has been provided at this time. Further information has been requested.